╌>

Stock Market - Orbital ATK: A buy tomorrow after expected pop on the open?

  

Category:  Stock Market & Investments

Via:  the-irascible-harry-krishner  •  9 years ago  •  13 comments

Stock Market - Orbital ATK: A buy tomorrow after expected pop on the open?

This Video is from 2/27 - Notice what Steve Weiss said about "Orbital ATK" (stock symbol OA). At that time the price was $67.42.

But tomorrow it might be a decent speculative (but very risky!) buy, I'm not recommending it!...perhaps a pop on the open, then a pullback at 9:30 -10:30 or so?

5 day chart .... closed Thurs at about the same price $67.75


Tags

jrDiscussion - desc
[]
 
Krishna
Professor Expert
link   seeder  Krishna    9 years ago

Watch what happens next.

(Also BX might be fun to watch tomorrow...Thurs close $39.14)

 
 
 
Randy
Sophomore Quiet
link   Randy    9 years ago

We don't have any money in the market. The money we do have is in boring FDIC bank accounts. I suppose we are actually losing a small amount of money that way, but we are retired and can not afford to gamble with any of it.

Our biggest investment is our home. We bought it at a steal price after the market collapsed and it's already increased in more then $125k in value and less then three years. That works for me.

 
 
 
Krishna
Professor Expert
link   seeder  Krishna    9 years ago

I was afraid OA would open too high to buy. Stock is up on a down day for markets. A great opportunity to buy stuff.

OA did move up a tad. But not all that much because the overall market is having a bad day. Bought some OA at $68.63. Will be interesting to watch what happens next...next week might be interesting...

(Note: This is a highly speculative stock-- none of what I've said is to be construed to either buy or sell any stocks).

 
 
 
Krishna
Professor Expert
link   seeder  Krishna    9 years ago

Generally speaking, real estate is a better investment over time than stocks. (Of course specifics can vary. With both its partly due to how smart you are in what you buy; how smart you are in when you buy it; and of course there are always unforeseen circumstance AKA "luck").

Stocks vary in terms of risk as well as reward (generally the two are inversely correlated-- the greater the potential reward, the greater the potential risk. Conversely, the lower the risk the lower the possible gain). Smart investors do a lot of research, and find things that have relatively good rewards with fairly low risk. (While there's always some risk with stocks such as Verizon or AT&T, General Motors, good healthcare-related stocks, defense companies such as Lockheed Martin or Northrup Grumman, etc. probably won't go bust anytime soon.

Note: Nothing I have said here is a recommendation to buy or sell any securities. Investing in equities involves risk, possibly including the loss of part or all of your invested capital.

 
 
 
Krishna
Professor Expert
link   seeder  Krishna    9 years ago

Another approach to stock investing is to buy safer stocks that don't move up or down much but that pay good dividends. And, importantly-- diversify!

Even if the stock stays flat for years, if you keep getting dividends and reinvest them you'll do well. (Generally safe stocks that pay 4% or better. If the dividend is much higher they get riskier unless you choose wisely.) Also, while good ones don't move much, over a few years they gradually go higher. (If yo get , say, 3 1/2% to 4%/year which you reinvest, plus stock moves up a few % points/year, over time you'll do well).

I currently try to buy larger amount of relatively safe stocks which pay 5% or more, but occasionally put very small amounts into speculative stocks that pay little or no dividends (such as OA, or IMGN, or OPK or BCLI ,).

Someone on NT who knows the industry recommened TRIB a while back- so far I have 7% gain which is pretty good. However, i expect it may be a takeover target-- in which case it should pop nicely.

 
 
 
Krishna
Professor Expert
link   seeder  Krishna    9 years ago

The money we do have is in boring FDIC bank accounts. I suppose we are actually losing a small amount of money that way, but we are retired and can not afford to gamble with any of it.

Interest rates on that sort of thing, as well as money market and decent bonds are horrendous. IMO rates will soon start to rise but very, very gradually. Great to have the bulk of your assets in a house. But it might pay to gradually over time strt to put somme of that bank accunt money into relativel safe dividend paying stocks. Safer stocks that pay, say, 3% to 4%.

 
 
 
Krishna
Professor Expert
link   seeder  Krishna    9 years ago

To re-iterate-- important: This applies to all my comments about the stock market:

Nothing I have said here is a recommendation to buy or sell any securities. Investing in equities involves risk, possibly including the loss of part or all of your invested capital.

 
 
 
Larry Hampton
Professor Quiet
link   Larry Hampton    9 years ago

Fingers crossed. I doubled my investment here last week.

:~)

 
 
 
Krishna
Professor Expert
link   seeder  Krishna    9 years ago

I bought small amounts of TRIB three times. I haven't been following it closely, so I just looked-- it closed today at $18.62. I have a good gain (just looked it up-- +6.87% which is god since I haven't owned it a long time).

It looks to me like the sort of stock that isn't very volatile-- no large sudden swings up and down. It seems to be a really solid company, so its probably not too risky. It looks like the kind of stock that over time mainly moves slowly but steadily upward-- unless/until a major event occurs-- such as:

1. Some brokerage house "discovers" it, and writes a favourable review. That usually results in a move upward. If that causes other brokerages to discover it it may continue upwards.(There's no way to predict when-- or if-- that happens).

2. If they win a major contract-- with a several hospitals.

3. Often the best event could be if a major company acquires them. Generally the price they pay per share is a lot higher than the market price. Then you would have the choice of selling it for a nice profit when the news is announced (before its actually taken over). Or keep it, which means you get to own shares of the large company absorbing it but getting those shares at a much lower price than market value. (Also, a larger company in heathcare usually pays a decent dividend).

 
 
 
Krishna
Professor Expert
link   seeder  Krishna    9 years ago

closed Thurs at about the same price $67.75

Its had a nice move, since its been only a week. Closed today at $75.36! Normally when a stock I own has a big more like that I wait for a dip to buy more, but today I bought a small additional amount at $75.32. It may continue to move up as there was an article about it in Barrons today after the close:

AHEAD OF THE CROWD

Orbital ATK Stock Can Rocket Higher

Shares of the satellite and weapons specialist Orbital ATK have rallied in the past month. But we spy 25% upside in the next year.

LINK

I could be wrong but it should see another nice move upward tomorrow. The question now is-- has it gotten too expensive to buy more?

 
 
 
Larry Hampton
Professor Quiet
link   Larry Hampton    9 years ago

My expectation is for the Meritas company of TRIB to see startling profit within a year of it's approval of the Troponin cardiac test. There is nothing in the US that will match it....

Cardiac Update

Trinity achieved some key milestones during 2014 relating to our new point-of-care cardiac products on the Meritas platform.CE marking was obtained for the company's new high sensitivity Troponin I test in Q1, 2014. The trial data as part of these trials demonstrated unrivalled performance for a point-of-care Troponin product.These results were subsequently corroborated by an independent trial carried out at Hennepin County Medical Centre, Minneapolis and published at the AACC meeting in July 2014.

FDA clinical trials for the product commenced in Q2, 2014 with enrolment initially taking place at 5 trial sites throughout the USA.Due to the impact of a format change in a chemical raw material used in the product, these clinical trials were temporarily suspended in October, 2014.After taking remedial action, the product's performance was restored and the resumption of trials was announced in February, 2015. Enrolment is now taking place at 12 sites in the USA with the entire trial process, consisting of patient sampling, data collection, cardiologist adjudication and statistical analysis, expected to be completed by the end of July, 2015 with FDA submission planned for August, 2015.

Significant progress was also made on the second test to be launched on the Meritas platform, BNP, which determines the risk of heart failure. CE Marking for this product was obtained in Q3, 2014 with FDA submission to follow in 2015. As with our Troponin I test, we are extremely confident that this product will obtain FDA approval based on its strong performance in trials to date.

- See more at:

 
 
 
Krishna
Professor Expert
link   seeder  Krishna    9 years ago

Thanks for the info!

I will read that,maybe buy a little more TRIB tomorrow, if I can scrape together some money.

 
 
 
Krishna
Professor Expert
link   seeder  Krishna    9 years ago

Watch What Happens Next

---> 5-day chart

 
 

Who is online